Effect of Metformin on Glycemic Control Regarding Carriers of the SLC22A1/OCT1 (rs628031) Polymorphism and Its Interactions with Dietary Micronutrients in Type 2 Diabetes

References

• An H, He L. Current understanding of metformin effect on the control of hyperglycemia in diabetes. J Endocrinol. 2016;228(3):R97–R106. doi:10.1530/JOE-15-0447
   PubMed Web of Science ®Google Scholar
• Jing Y, Wu F, Li D, Yang L, Li Q, Li R. Metformin improves obesity-associated inflammation by altering macrophages polarization. Mol Cell Endocrinol. 2018;461:256–264. doi:10.1016/j.mce.2017.09.025
   PubMed Web of Science ®Google Scholar
• Yerevanian A, Soukas AA. Metformin: mechanisms in human obesity and weight loss. Curr Obes Rep. 2019;8(2):156–164. doi:10.1007/s13679-019-00335-3
   PubMed Web of Science ®Google Scholar
• Le S, Lee GC. Emerging trends in metformin prescribing in the United States from 2000 to 2015. Clin Drug Investig. 2019;39(8):757–763. doi:10.1007/s40261-019-00799-0
   PubMed Web of Science ®Google Scholar
• Madiraju AK, Erion DM, Rahimi Y, et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature. 2014;510(7506):542–546. doi:10.1038/nature13270
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 8. obesity management for the treatment of type 2 diabetes: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl1):S100–S110. doi:10.2337/dc21-S008.
   PubMed Web of Science ®Google Scholar
• Lu X, Dong Y, Jian Z, et al. Systematic investigation of the effects of long-term administration of a high-fat diet on drug transporters in the mouse liver, kidney and intestine. Curr Drug Metab. 2019;20(9):742–755. doi:10.2174/1389200220666190902125435
   Web of Science ®Google Scholar
• Mofo Mato EP, Guewo-Fokeng M, Essop MF, Owira PMO. Genetic polymorphisms of organic cation transporter 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes: a systematic review. Medicine. 2018;97(27):e11349. doi:10.1097/MD.0000000000011349
   Web of Science ®Google Scholar
• Nasykhova YA, Tonyan ZN, Mikhailova AA, Danilova MM, Glotov AS. Pharmacogenetics of Type 2 diabetes-progress and prospects. Int J Mol Sci. 2020;21(18):E6842. doi:10.3390/ijms21186842
   PubMed Web of Science ®Google Scholar
• Torres-Valadez R, Ramos-Lopez O, Frías Delgadillo KJ, et al. Impact of APOE alleles-by-diet interactions on glycemic and lipid features- a cross-sectional study of a cohort of type 2 diabetes patients from Western Mexico: implications for personalized medicine. Pharmgenomics Pers Med. 2020;13:655–663. doi:10.2147/PGPM.S277952
   Web of Science ®Google Scholar
• World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194. doi:10.1001/jama.2013.281053.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(Suppl 1):S62–69. doi:10.2337/dc10-S062.
   PubMed Web of Science ®Google Scholar
• Torres-Castillo N, Campos-Perez W, Gonzalez-Becerra K, et al. Waist circumference is an anthropometric parameter that identifies women with metabolically unhealthy phenotypes. Nutrients. 2018;10(4):E447. doi:10.3390/nu10040447
   Web of Science ®Google Scholar
• WHO consultation on obesity(1999: Geneva S, World Health Organization). Obesity: preventing and managing the global epidemic: report of a WHO consultation. World Health Organization; 2000. Accessed November 14, 2021. https://apps.who.int/iris/handle/10665/42330.
   Google Scholar
• SMAE-4a-ed-Ana-Bertha-P®rez-Lizaur.pdf. Available from: https://www.cdefis.com/wp-content/uploads/2020/01/SMAE-4a-ed-Ana-Bertha-P%C2%AErez-Lizaur.pdf. Accessed November 14, 2021.
   Google Scholar
• Official Mexican Standard NOM-015-SSA2-2010, for prevention, treatment and control of diabetes mellitus. Available from: http://www.dof.gob.mx/normasOficiales/4215/salud/salud.htm. Accessed November 9, 2021.
   Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502. doi:10.1093/clinchem/18.6.499
   PubMed Web of Science ®Google Scholar
• Navarro-González D, Sánchez-íñigo L, Pastrana-Delgado J, Fernández-Montero A, Martinez JA. Triglyceride-glucose index (TyG index) in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose: the vascular-metabolic CUN cohort. Prev Med. 2016;86:99–105. doi:10.1016/j.ypmed.2016.01.022
   PubMed Web of Science ®Google Scholar
• National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–3421. doi:10.1161/circ.106.25.3143
   PubMed Web of Science ®Google Scholar
• Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215. doi:10.1093/nar/16.3.1215
   PubMed Web of Science ®Google Scholar
• Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia. 2017;60(9):1577–1585. doi:10.1007/s00125-017-4342-z
   PubMed Web of Science ®Google Scholar
• You Y, Doubova SV, Pinto-Masis D, Pérez-Cuevas R, Borja-Aburto VH, Hubbard A. Application of machine learning methodology to assess the performance of DIABETIMSS program for patients with type 2 diabetes in family medicine clinics in Mexico. BMC Med Inform Decis Mak. 2019;19(1):221. doi:10.1186/s12911-019-0950-5
   Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes–2014. Diabetes Care. 2014;37(Suppl 1):S14–80. doi:10.2337/dc14-S014.
   PubMed Web of Science ®Google Scholar
• NICE. Overview | type 2 diabetes in adults: management | guidance | NICE. Available from: https://www.nice.org.uk/guidance/ng28. Accessed November 14, 2021.
   Google Scholar
• U.K. Prospective Diabetes Study Group. U.K. prospective diabetes study 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes. 1995;44(11):1249–1258. doi:10.2337/diab.44.11.1249
   PubMed Web of Science ®Google Scholar
• Weir GC, Bonner-Weir S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes. 2004;53(Suppl 3):S16–21. doi:10.2337/diabetes.53.suppl_3.s16
   PubMed Web of Science ®Google Scholar
• Ramos-Lopez O, Panduro A, Rivera-Iñiguez I, Roman S. Dopamine D2 receptor polymorphism (C957T) is associated with sugar consumption and triglyceride levels in West Mexicans. Physiol Behav. 2018;194:532–537. doi:10.1016/j.physbeh.2018.07.004
   Web of Science ®Google Scholar
• Santiago-Torres M, Kratz M, Lampe JW, et al. Metabolic responses to a traditional Mexican diet compared with a commonly consumed US diet in women of Mexican descent: a randomized crossover feeding trial. Am J Clin Nutr. 2016;103(2):366–374. doi:10.3945/ajcn.115.119016
   Web of Science ®Google Scholar
• Reséndiz-Abarca CA, Flores-Alfaro E, Suárez-Sánchez F, et al. Altered glycemic control associated with polymorphisms in the SLC22A1 (OCT1) gene in a Mexican Population with type 2 diabetes mellitus treated with metformin: a cohort study. J Clin Pharmacol. 2019;59(10):1384–1390. doi:10.1002/jcph.1425
   Web of Science ®Google Scholar
• Rotroff DM, Yee SW, Zhou K, et al. Genetic variants in CPA6 and PRPF31 are associated with variation in response to metformin in individuals with type 2 diabetes. Diabetes. 2018;67(7):1428–1440. doi:10.2337/db17-1164
   PubMed Web of Science ®Google Scholar
• Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of type 2 diabetes – global burden of disease and forecasted trends. J Epidemiol Glob Health. 2020;10(1):107–111. doi:10.2991/jegh.k.191028.001
   PubMed Web of Science ®Google Scholar
• Global report on diabetes. Available from: https://www.who.int/publications-detail-redirect/9789241565257. Accessed November 14, 2021.
   Google Scholar
• Ramos-Lopez O, Mejia-Godoy R, Frías-Delgadillo KJ, et al. Interactions between DRD2/ANKK1 TaqIA polymorphism and dietary factors influence plasma triglyceride concentrations in diabetic patients from Western Mexico: a cross-sectional study. Nutrients. 2019;11(12):E2863. doi:10.3390/nu11122863
   Web of Science ®Google Scholar
• Kanis JA, Harvey NC, McCloskey E, et al. Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Osteoporos Int. 2020;31(1):1–12. doi:10.1007/s00198-019-05176-3
   PubMed Web of Science ®Google Scholar
• Al-Saleh Y, Al-Daghri NM, Sabico S, et al. Diagnosis and management of osteoporosis in postmenopausal women in Gulf Cooperation Council (GCC) countries: consensus statement of the GCC countries’ osteoporosis societies under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Arch Osteoporos. 2020;15(1):109. doi:10.1007/s11657-020-00778-5
   Web of Science ®Google Scholar
• Towler MC, Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res. 2007;100(3):328–341. doi:10.1161/01.RES.0000256090.42690.05
   PubMed Web of Science ®Google Scholar
• Foretz M, Guigas B, Viollet B. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus. Nat Rev Endocrinol. 2019;15(10):569–589. doi:10.1038/s41574-019-0242-2
   PubMed Web of Science ®Google Scholar
• Banerjee J, Bruckbauer A, Zemel MB. Activation of the AMPK/Sirt1 pathway by a leucine-metformin combination increases insulin sensitivity in skeletal muscle, and stimulates glucose and lipid metabolism and increases life span in Caenorhabditis elegans. Metabolism. 2016;65(11):1679–1691. doi:10.1016/j.metabol.2016.06.011
   PubMed Web of Science ®Google Scholar
• Ido Y. Diabetic complications within the context of aging: nicotinamide adenine dinucleotide redox, insulin C-peptide, sirtuin 1-liver kinase B1-adenosine monophosphate-activated protein kinase positive feedback and forkhead box O3. J Diabetes Investig. 2016;7(4):448–458. doi:10.1111/jdi.12485
   PubMed Web of Science ®Google Scholar
• Zang Y, Fan L, Chen J, Huang R, Qin H. Improvement of lipid and glucose metabolism by capsiate in palmitic acid-treated HepG2 cells via activation of the AMPK/SIRT1 signaling pathway. J Agric Food Chem. 2018;66(26):6772–6781. doi:10.1021/acs.jafc.8b01831
   Web of Science ®Google Scholar
• Fu L, Bruckbauer A, Li F, et al. Leucine amplifies the effects of metformin on insulin sensitivity and glycemic control in diet-induced obese mice. Metabolism. 2015;64(7):845–856. doi:10.1016/j.metabol.2015.03.007
   PubMed Web of Science ®Google Scholar
• Richter EA, Hargreaves M. Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol Rev. 2013;93(3):993–1017. doi:10.1152/physrev.00038.2012
   PubMed Web of Science ®Google Scholar
• Fogarty S, Hawley SA, Green KA, Saner N, Mustard KJ, Hardie DG. Calmodulin-dependent protein kinase kinase-β activates AMPK without forming a stable complex: synergistic effects of Ca2+ and AMP. Biochem J. 2010;426(Pt1):109–118. doi:10.1042/BJ20091372
   Web of Science ®Google Scholar
• Swulius MT, Waxham MN. Ca2+/Calmodulin-dependent protein kinases. Cell Mol Life Sci. 2008;65(17):2637–2657. doi:10.1007/s00018-008-8086-2
   PubMed Web of Science ®Google Scholar
• Shibata M, Toyoshima J, Kaneko Y, Oda K, Nishimura T. A drug-drug interaction study to evaluate the impact of peficitinib on OCT1- and MATE1-mediated transport of metformin in healthy volunteers. Eur J Clin Pharmacol. 2020;76(8):1135–1141. doi:10.1007/s00228-020-02876-2
   PubMed Web of Science ®Google Scholar